ATE378054T1 - Mittel zu linderung von hyperglykämie nach dem essen - Google Patents

Mittel zu linderung von hyperglykämie nach dem essen

Info

Publication number: ATE378054T1
Authority: AT; Austria
Prior art keywords: remedy; eating; levels reduced; cholesterol; hyperglycemia
Prior art date: 2001-07-30

Application number

AT02749378T

Other languages

English (en)

Inventor

Kenzo Oba

Original Assignee

Mitsubishi Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-30

Filing date

2002-07-29

Publication date

2007-11-15

2002-07-29 Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp

2007-11-15 Application granted granted Critical

2007-11-15 Publication of ATE378054T1 publication Critical patent/ATE378054T1/de

Links

201000001421 hyperglycemia Diseases 0.000 title 1
239000008280 blood Substances 0.000 abstract 2
210000004369 blood Anatomy 0.000 abstract 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
DEMLYXMVPJAVFU-UHFFFAOYSA-N 2-(chloromethyl)oxirane;2-methyl-1h-imidazole Chemical compound ClCC1CO1.CC1=NC=CN1 DEMLYXMVPJAVFU-UHFFFAOYSA-N 0.000 abstract 1
239000003957 anion exchange resin Substances 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
230000003178 anti-diabetic effect Effects 0.000 abstract 1
230000002402 anti-lipaemic effect Effects 0.000 abstract 1
239000003472 antidiabetic agent Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

AT02749378T 2001-07-30 2002-07-29 Mittel zu linderung von hyperglykämie nach dem essen ATE378054T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2001229087		2001-07-30

Publications (1)

Publication Number	Publication Date
ATE378054T1 true ATE378054T1 (de)	2007-11-15

Family

ID=19061486

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02749378T ATE378054T1 (de)	2001-07-30	2002-07-29	Mittel zu linderung von hyperglykämie nach dem essen

Country Status (11)

Country	Link
US (1)	US7879869B2 (de)
EP (1)	EP1413309B1 (de)
JP (1)	JP4353414B2 (de)
KR (1)	KR100924478B1 (de)
CN (1)	CN1270724C (de)
AT (1)	ATE378054T1 (de)
CA (1)	CA2454732C (de)
DE (1)	DE60223551T2 (de)
ES (1)	ES2295369T3 (de)
TW (1)	TWI324519B (de)
WO (1)	WO2003011308A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6733780B1 (en)	1999-10-19	2004-05-11	Genzyme Corporation	Direct compression polymer tablet core
ES2397159T3 (es) *	2004-03-26	2013-03-05	Mitsubishi Tanabe Pharma Corporation	Agente mejorador de la resistencia a insulina
WO2006041150A1 (ja) *	2004-10-15	2006-04-20	Mitsubishi Pharma Corporation	糖尿病の予防および／または治療薬
US7985418B2 (en)	2004-11-01	2011-07-26	Genzyme Corporation	Aliphatic amine polymer salts for tableting
EP1951266A2 (de)	2005-09-02	2008-08-06	Genzyme Corporation	Verfahren zur entfernung von phosphat und dafür verwendetes polymer
PT1924246E (pt)	2005-09-15	2016-02-10	Genzyme Corp	Formulação sachê para polímeros com funcionalidade amina
ES2398477T3 (es) *	2006-06-16	2013-03-19	Mitsubishi Tanabe Pharma Corporation	Agente para la prevención y/o el tratamiento de glomerulopatía
WO2008042222A2 (en)	2006-09-29	2008-04-10	Genzyme Corporation	Amide dendrimer compositions
EP2120972A1 (de)	2006-12-14	2009-11-25	Genzyme Corporation	Amido-amin-polymerzusammensetzungen
US8524212B2 (en) *	2007-10-24	2013-09-03	Mitsubishi Tanabe Pharma Corporation	Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitis
CN106478948B (zh) *	2010-02-24	2019-05-07	瑞立普萨公司	用作胆汁酸螯合剂的聚咪唑
JP2014129284A (ja) *	2012-12-28	2014-07-10	Nof Corp	食後血糖上昇抑制剤
CN106366311B (zh) *	2015-07-23	2019-08-13	山东诚创医药技术开发有限公司	一种考来替兰的制备方法
CN106359772A (zh) *	2016-11-30	2017-02-01	广西百利乐生物科技有限公司	防止沉淀的果汁凉茶的浓缩提取液及其加工方法
CN106720731A (zh) *	2016-11-30	2017-05-31	广西百利乐生物科技有限公司	高透光率的果汁凉茶的浓缩提取液及其加工工艺
KR101969719B1 (ko)	2017-07-04	2019-04-17	한남대학교 산학협력단	리시닐-프럭토오즈(Lysinyl-Fructose, LF)를 포함하는 혈당상승 억제제 및 그 제조방법
KR102043461B1 (ko)	2017-12-21	2019-11-11	주식회사 프로테인웍스	아스코르빈산 및 니아신을 포함하는 식후 혈당상승억제용 조성물
KR20230057134A (ko)	2021-10-21	2023-04-28	한가람비앤에프 주식회사	해죽순 추출물을 포함하는 식후 혈당상승억제용 조성물
KR102450000B1 (ko)	2022-02-20	2022-09-30	이용호	커피 추출물을 포함하는 식후 혈당상승억제용 조성물
KR20230174959A (ko)	2022-06-22	2023-12-29	농업회사법인 그린생명주식회사	아마도리 화합물을 고농도로 함유하는 홍삼 추출물을 포함하는 식후 혈당상승억제용 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60209523A (ja)	1984-04-03	1985-10-22	Mitsubishi Petrochem Co Ltd	コレステロ−ル低下剤
CA2052014A1 (en)	1990-10-19	1992-04-20	Henry Y. Pan	Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5468727A (en)	1990-12-13	1995-11-21	Board Of Regents, The University Of Texas System	Methods of normalizing metabolic parameters in diabetics
US5607669A (en)	1994-06-10	1997-03-04	Geltex Pharmaceuticals, Inc.	Amine polymer sequestrant and method of cholesterol depletion
CA2129079C (en) *	1993-08-03	2006-01-17	Tatsuo Nomura	Orally administrable cholesterol lowering agent
US5496545A (en) *	1993-08-11	1996-03-05	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
DK0815857T3 (da)	1995-12-26	2005-01-24	Suntory Ltd	Anti-adipöst middel indeholdende procyanidin som den aktive ingrediens
US5859051A (en) *	1996-02-02	1999-01-12	Merck & Co., Inc.	Antidiabetic agents
US5847008A (en) *	1996-02-02	1998-12-08	Merck & Co., Inc.	Method of treating diabetes and related disease states
TW528597B (en) *	1996-03-05	2003-04-21	Mitsubishi Electric Corp	Medicament for preventive and/or therapeutic treatment of hyperphosphatemia
US6011049A (en) *	1997-02-19	2000-01-04	Warner-Lambert Company	Combinations for diabetes
ES2206868T3 (es)	1998-07-15	2004-05-16	Merck Sante	Comprimidos que comprenden una combinacion de metformin glibenclamida.
AU7856200A (en) *	1999-10-07	2001-05-10	University Of Maryland	Sugar binding polymers and the use thereof
MXPA03000694A (es) *	2000-07-28	2003-06-04	Hoffmann La Roche	Nuevo uso de los inhibidores de lipasa.
AU2002224109A1 (en) *	2000-11-28	2002-06-11	Mitsubishi Pharma Corporation	Excretion accelerator for accumulative chlorine compound

2002
- 2002-07-29 WO PCT/JP2002/007655 patent/WO2003011308A1/ja not_active Ceased
- 2002-07-29 CN CNB028150287A patent/CN1270724C/zh not_active Expired - Fee Related
- 2002-07-29 ES ES02749378T patent/ES2295369T3/es not_active Expired - Lifetime
- 2002-07-29 EP EP02749378A patent/EP1413309B1/de not_active Expired - Lifetime
- 2002-07-29 KR KR1020047001122A patent/KR100924478B1/ko not_active Expired - Fee Related
- 2002-07-29 DE DE60223551T patent/DE60223551T2/de not_active Expired - Lifetime
- 2002-07-29 TW TW091116915A patent/TWI324519B/zh not_active IP Right Cessation
- 2002-07-29 AT AT02749378T patent/ATE378054T1/de not_active IP Right Cessation
- 2002-07-29 CA CA2454732A patent/CA2454732C/en not_active Expired - Lifetime
- 2002-07-29 JP JP2003516538A patent/JP4353414B2/ja not_active Expired - Fee Related
- 2002-07-29 US US10/485,217 patent/US7879869B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1537010A (zh)	2004-10-13
ES2295369T3 (es)	2008-04-16
US20040191209A1 (en)	2004-09-30
TWI324519B (en)	2010-05-11
US7879869B2 (en)	2011-02-01
CA2454732C (en)	2010-07-20
DE60223551T2 (de)	2008-10-23
EP1413309A1 (de)	2004-04-28
KR20040030858A (ko)	2004-04-09
EP1413309A4 (de)	2006-06-07
CA2454732A1 (en)	2003-02-13
JP4353414B2 (ja)	2009-10-28
EP1413309B1 (de)	2007-11-14
CN1270724C (zh)	2006-08-23
WO2003011308A1 (en)	2003-02-13
KR100924478B1 (ko)	2009-11-03
JPWO2003011308A1 (ja)	2004-11-18
DE60223551D1 (de)	2007-12-27

Similar Documents

Publication	Publication Date	Title
ATE378054T1 (de)	2007-11-15	Mittel zu linderung von hyperglykämie nach dem essen
Brown et al.	2019	A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium‐glucose co‐transporter‐2 inhibitors
Berger et al.	1997	Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients
WO2002058684A3 (en)	2003-04-17	Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
UY26425A1 (es)	2001-07-31	Formulación y método antidiabético
NO20090846L (no)	1999-12-17	Kombinasjon og farmasoytisk blanding for behandling av diabetes samt anvendelse derav
MX9703694A (es)	1998-02-28	Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
WO2001090091A8 (en)	2002-07-25	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
ATE330588T1 (de)	2006-07-15	Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen
Greenway et al.	1999	Double‐blind, randomized, placebo‐controlled clinical trials with non‐prescription medications for the treatment of obesity
BR0001794A (pt)	2001-12-26	Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
EP1393738A4 (de)	2004-11-17	Arzneimittel gegen diabetes
Lee et al.	1987	Chronic effects of an alpha-glucosidase inhibitor (Bay o 1248) on intestinal disaccharidase activity in normal and diabetic mice.
Lettieri et al.	1998	Effects of beano on the tolerability and pharmacodynamics of acarbose
Cerasi et al.	1979	Effect Of Two Sulphonylureas On The Dose Kinetics Of Glucose–Induced Insulin Release In Normal And Diabetic Subjects
NO985676L (no)	1998-12-04	Forbindelser med colchicinstruktur, deres anvendelse som legemidler og blan
BR9915962A (pt)	2003-01-07	Composto da série do piridìnio, processos para a preparação de composto da série do piridìnio e de uma formulação parenteral, uso de um composto, composição farmacêutica para tratar complicações diabéticas e doenças associadas ao envelhecimento, e, método para tratar um paciente diabético e para prevenir ou tratar doenças causadas por complicações associadas à diabetes e ao envelhecimento
BR0103209A (pt)	2002-03-26	Uso de ácido fitânico para o tratamento de diabetes
Finer et al.	1992	Drug therapy after very-low-calorie diets
NO985807D0 (no)	1998-12-11	Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament
Kaur et al.	2006	Toxic effects of subacute oral exposure of imidacloprid on biochemical parameters in crossbred cow calves
EP1447090B8 (de)	2012-02-22	Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen
BR0009704A (pt)	2002-01-08	Utilização do osanetant para a preparação de medicamentos úteis no tratamento das perturbações do humor
AU2003285426A1 (en)	2004-05-13	Use of tenatoprazole for the treatment of gastroesophageal reflux
St. Amand et al.	1997	The use of uricosuric agents in fibromyalgia: theory, practice, and a rebuttal to the Oregon study of guaifenesin treatment

Legal Events

Date	Code	Title	Description
2008-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties